The long term goal is to identify molecular mechanisms for the onset of accelerated atherosclerosis in diabetes mellitus. This will be accomplished by studying animal models susceptible to both diabetes and atherosclerosis. The investigators have now developed several mouse models which show accelerated atherosclerosis upon becoming diabetic. These include the BALB/c strain treated with streptozotocin and fed a high fat/cholesterol diet, and diabetic NOD mice. These and other mouse strains will be used to identify genetic and environmental factors influencing atherosclerosis due to the diabetic state, and to explore possible steps toward treatment or prevention of atherosclerosis disease in diabetics. There are four specific aims.
The first aim i s to characterize lesion cellular composition and vascular sites of development. Immunocytochemical and histological approaches will be used. The hypothesis is that diabetes induces differences in lesion composition and location in the vasculature.
The second aim i s to identify biochemical pathways through which hyperglycemia and dyslipidemia enhance oxidation at the artery wall and in model tissues using gas chromatography/mass spectroscopy and specific antibodies. The investigators hypothesize a role for oxidation in accelerated atherosclerosis.
The third aim i s to determine whether hyperglycemia and dyslipidemia alter the expression of inflammatory genes and matrix molecules at the artery wall and in model tissues. Gene expression will be studied at the level of mRNA and protein in artery wall and liver tissues.
The fourth aim i s to determine whether atherosclerosis can be ameliorated by treatment with insulin and/or dietary anti-oxidants. In summary, the investigators have created a panel of mouse models which can be compared and contrasted as to the mechanisms leading to atherosclerosis onset in the diabetic state. Studies will also be initiated toward identifying treatments to retard or reverse atherosclerosis in diabetics.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL052848-05
Application #
6389382
Study Section
Metabolism Study Section (MET)
Program Officer
Wassef, Momtaz K
Project Start
1997-02-01
Project End
2002-08-30
Budget Start
2001-04-01
Budget End
2002-08-30
Support Year
5
Fiscal Year
2001
Total Cost
$271,378
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Li, Yu-I; Elmer, Gary; Leboeuf, Renee C (2008) Tanshinone IIA reduces macrophage death induced by hydrogen peroxide by upregulating glutathione peroxidase. Life Sci 83:557-62
Kanter, Jenny E; Johansson, Fredrik; LeBoeuf, Renee C et al. (2007) Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? Circ Res 100:769-81
Tannock, Lisa R; Kirk, Elizabeth A; King, Victoria L et al. (2006) Glucosamine supplementation accelerates early but not late atherosclerosis in LDL receptor-deficient mice. J Nutr 136:2856-61
O'Brien, Kevin D; McDonald, Thomas O; Kunjathoor, Vidya et al. (2005) Serum amyloid A and lipoprotein retention in murine models of atherosclerosis. Arterioscler Thromb Vasc Biol 25:785-90
McMillen, Timothy S; Heinecke, Jay W; LeBoeuf, Renee C (2005) Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice. Circulation 111:2798-804
Ladiges, Warren C; Knoblaugh, Sue E; Morton, John F et al. (2005) Pancreatic beta-cell failure and diabetes in mice with a deletion mutation of the endoplasmic reticulum molecular chaperone gene P58IPK. Diabetes 54:1074-81
Muhlfeld, Anja S; Spencer, Min W; Hudkins, Kelly L et al. (2004) Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice. Kidney Int 66:1393-402
Shultz, Jennifer M; Zhu, Xiao Dong; Knopp, Robert H et al. (2004) Norgestimate and medroxyprogesterone acetate do not attenuate the atheroprotective effects of 17beta-estradiol in ovariectomized, apolipoprotein E-deficient mice. Fertil Steril 82 Suppl 3:1133-9
Vidal, J; Verchere, C Bruce; Andrikopoulos, S et al. (2003) The effect of apolipoprotein E deficiency on islet amyloid deposition in human islet amyloid polypeptide transgenic mice. Diabetologia 46:71-9
Schreyer, Sandra A; Lystig, Theodore C; Vick, Cynthia M et al. (2003) Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity. Atherosclerosis 171:49-55

Showing the most recent 10 out of 23 publications